RxDoctor Payments Data

Victoria Jaeger, DO

Gastroenterology · Nampa, IDNPI 1770938318

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $264 and has fallen 75.4% since, to $65 in 2025. That places this record below the midpoint for gastroenterology clinicians in ID, where the typical reported total is $1,538.

$624in general payments, 2019–2025

Across 23 payments — averaging $27.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$129
  • E.r. Squibb & Sons, L.L.C.$109
  • AbbVie$74
  • AstraZeneca$67
  • Phathom Pharmaceuticals, Inc.$47
  • Organon$41
  • plus $157 from 7 others

What the payments were for

  • Food & beverage$624100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$624 in reported general payments places this provider in the 30th percentile of 70 gastroenterology providers in Idaho.

See all gastroenterology providers in Idaho

Medicare billing

Part B allowed, 2024
$70,407
Medicare patients
321
Services billed
777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates245$15,449
Budesonide DrBudesonide15$3,174
Omeprazole152$2,394
Ondansetron OdtOndansetron301$1,586
Sucralfate17$1,061
Famotidine32$986
Pantoprazole Sodium90$896
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl39$489
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl24$454
Esomeprazole Magnesium12$417
Metronidazole12$193

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Nampa

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →